Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Sellgren

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|November 7, 2015
CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorderJoel Jakobsson, Erik Pålsson, Carl Sellgren, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 29, 2017
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controlsErik Pålsson, Carl Sellgren, Eleonore Rydén, et al.
Plos One|May 9, 2015
Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controlsSindre Rolstad, Joel Jakobsson, Carl Sellgren, et al.
Brain, Behavior, and Immunity|May 10, 2017
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomesAnniella Isgren, Carl Sellgren, Carl-Johan Ekman, et al.
Journal of Psychiatry & Neuroscience : JPN|February 19, 2013
Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorderJoel Jakobsson, Mats Stridsberg, Henrik Zetterberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 4, 2014
Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patientsJoel Jakobsson, Maria Bjerke, Carl Johan Ekman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 9, 2014
Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controlsErik Pålsson, Joel Jakobsson, Kristoffer Södersten, et al.
Plos One|January 24, 2015
Cognitive functioning in clinically stable patients with bipolar disorder I and IITimea Sparding, Katja Silander, Erik Pålsson, et al.
Brain, Behavior, and Immunity|December 3, 2014
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatmentAnniella Isgren, Joel Jakobsson, Erik Pålsson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 31, 2015
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairmentSindre Rolstad, Joel Jakobsson, Carl Sellgren, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The British Journal of Psychiatry : the Journal of Mental Science|November 7, 2015
CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorderJoel Jakobsson, Erik Pålsson, Carl Sellgren, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 29, 2017
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controlsErik Pålsson, Carl Sellgren, Eleonore Rydén, et al.
Plos One|May 9, 2015
Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controlsSindre Rolstad, Joel Jakobsson, Carl Sellgren, et al.
Brain, Behavior, and Immunity|May 10, 2017
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomesAnniella Isgren, Carl Sellgren, Carl-Johan Ekman, et al.
Journal of Psychiatry & Neuroscience : JPN|February 19, 2013
Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorderJoel Jakobsson, Mats Stridsberg, Henrik Zetterberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 4, 2014
Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patientsJoel Jakobsson, Maria Bjerke, Carl Johan Ekman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 9, 2014
Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controlsErik Pålsson, Joel Jakobsson, Kristoffer Södersten, et al.
Plos One|January 24, 2015
Cognitive functioning in clinically stable patients with bipolar disorder I and IITimea Sparding, Katja Silander, Erik Pålsson, et al.
Brain, Behavior, and Immunity|December 3, 2014
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatmentAnniella Isgren, Joel Jakobsson, Erik Pålsson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 31, 2015
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairmentSindre Rolstad, Joel Jakobsson, Carl Sellgren, et al.
Pageof 3